元基因组组定序市场规模、份额、成长分析、按产品类型、按技术、按应用、按最终用户、按地区 - 行业预测，2024-2031 年

2022年全球元基因组体定序市场规模为18亿美元，从2023年的21.2亿美元成长到2031年的76.8亿美元，预计复合年增长率为17.5%。

由于人们对了解复杂微生物群落及其对人类健康、生态系统和工业功能的影响日益感兴趣，全球元基因组定序市场正在强劲成长。主要应用包括临床诊断、农业研究、环境监测和药物发现。次世代定序技术的采用和定序成本的下降正在推动学术机构、研究机构和製药公司的市场扩张。此外，感染疾病率的上升和个人化医疗的需求正在推动市场的持续復苏。然而，资料分析、标准化和隐私问题等挑战可能会为这个动态领域的持续成长带来风险。整体而言，元基因组组定序可能在各个科学领域中发挥重要作用。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 监管环境
• 专利分析
• 案例研究

依产品类型和复合年增长率分類的元基因组定序市场规模（2024-2031）

• 市场概况
• 装置
  • 定序系统
  • 样品製备系统
• 消耗品
  • 试剂和套件
  • 微孔盘
• 软体
  • 资料分析软体
  • 储存和管理软体

元基因组体定序市场规模：依技术及复合年增长率（2024-2031）

• 市场概况
• 16S RRNA定序
• 鸟枪法宏基因组定序
• 全基因组序列分析
• 元转录组学

元基因组体定序市场规模：依应用和复合年增长率（2024-2031）

• 市场概况
• 临床诊断
  • 感染疾病诊断
  • 癌症诊断
• 药物发现
  • 微生物组分析
  • 病原鑑定
• 环境应用
  • 土壤微生物分析
  • 水微生物组分析
• 工业用途
  • 生质燃料生产
  • 生物修復

元基因组体定序市场规模：依最终用户和复合年增长率（2024-2031）

• 市场概况
• 製药和生物技术公司
  • 药物开发
  • 品管
• 学术研究所
  • 基础调查
  • 转化研究
• 医院/诊所
  • 诊断实验室
  • 临床调查

元基因组体定序市场规模与复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Illumina, Inc.（USA）
• Thermo Fisher Scientific Inc.（USA）
• QIAGEN NV（Netherlands）
• PerkinElmer, Inc.（USA）
• Oxford Nanopore Technologies Ltd.（UK）
• Pacific Biosciences of California, Inc.（USA）
• BGI Group（China）
• PSomagen, Inc.（USA）
• Eurofins Scientific（Luxembourg）
• Macrogen, Inc.（South Korea）
• Bio-Rad Laboratories, Inc.（USA）
• Promega Corporation（USA）
• Zymo Research Corporation（USA）
• NuGEN Technologies, Inc.（USA）
• Takara Bio Inc.（Japan）
• Swift Biosciences, Inc.（USA）
• Hamilton Company（USA）

结论和建议

Global Metagenomic Sequencing Market size was valued at USD 1.8 billion in 2022 and is poised to grow from USD 2.12 billion in 2023 to USD 7.68 billion by 2031, growing at a CAGR of 17.5% during the forecast period (2024-2031).

The global metagenomic sequencing market is witnessing robust growth, propelled by the surging interest in understanding complex microbial communities and their effects on human health, ecosystems, and industrial functions. Key applications include clinical diagnostics, agricultural research, environmental monitoring, and drug discovery. The adoption of next-generation sequencing technologies and falling sequencing costs are catalyzing market expansion among academic institutions, research bodies, and pharmaceutical companies. Furthermore, the rising incidence of infectious diseases and the demand for personalized medicine are contributing to continued market vitality. However, challenges such as data analysis, standardization, and privacy issues may pose risks to ongoing growth in this dynamic sector. Overall, metagenomic sequencing is poised to play a crucial role in various scientific fields.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Metagenomic Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Metagenomic Sequencing Market Segmental Analysis

Global Metagenomic Sequencing Market is segmented by product type, technology, application, end-user and region. Based on product type, the market is segmented into instruments, consumables and software. Based on technology, the market is segmented into 16S rRNA sequencing, shotgun metagenomic sequencing, whole-genome sequencing and metatranscriptomics. Based on application, the market is segmented into clinical diagnostics, drug discovery, environmental applications and industrial applications. Based on end-user, the market is segmented into pharmaceutical & biotechnology companies, academic & research institutes and hospitals & clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Metagenomic Sequencing Market

One significant factor fuelling the global metagenomic sequencing market is the rising demand for personalized healthcare. As advancements in metagenomic sequencing allow for an in-depth analysis of the microbial communities inhabiting an individual's body, healthcare professionals can gain critical insights into a person's unique microbiome and its implications for overall health. This information is essential in crafting tailored treatment strategies, assessing disease risk, and selecting the most effective therapies. The growing awareness of the microbiome's influence on health, coupled with the promising advantages posed by metagenomic sequencing, has significantly increased the appetite for this innovative technology in the medical field.

Restraints in the Global Metagenomic Sequencing Market

One of the primary challenges facing the global metagenomic sequencing market is the prohibitive costs linked with the technology. The intricate processes involved in metagenomic sequencing-including sample preparation, data analysis, and interpretation-necessitate the use of advanced equipment and highly skilled personnel. These factors contribute to substantial expenses for both sequencing and the accompanying bioinformatics analysis, thus hindering widespread implementation, particularly in resource-constrained environments. Furthermore, the extensive volume of data produced from metagenomic sequencing demands advanced computational resources for efficient analysis, which exacerbates the overall financial burden associated with the technology and limits its accessibility.

Market Trends of the Global Metagenomic Sequencing Market

The global metagenomic sequencing market is experiencing robust growth, propelled by increasing demand for personalized medicine and improved disease characterization. The advancement of sequencing technologies combined with sophisticated bioinformatics tools has enhanced data analysis capabilities, fostering wider adoption across clinical and research domains. Additionally, the utilization of metagenomic sequencing in environmental monitoring and agricultural applications is contributing to market expansion. Collaborative efforts between research institutions and biotechnology firms are driving innovation, attracting significant investment. However, challenges relating to data management, regulatory compliance, and standardization are critical considerations that could impact the market's trajectory and necessitate ongoing attention for sustained advancement.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Metagenomic Sequencing Market Size by Product Type & CAGR (2024-2031)

• Market Overview
• Instruments
  • Sequencing Systems
  • Sample Preparation Systems
• Consumables
  • Reagents & Kits
  • Microplates
• Software
  • Data Analysis Software
  • Storage & Management Software

Global Metagenomic Sequencing Market Size by Technology & CAGR (2024-2031)

• Market Overview
• 16S Rrna Sequencing
• Shotgun Metagenomic Sequencing
• Whole-Genome Sequencing
• Metatranscriptomics

Global Metagenomic Sequencing Market Size by Application & CAGR (2024-2031)

• Market Overview
• Clinical Diagnostics
  • Infectious Disease Diagnosis
  • Cancer Diagnosis
• Drug Discovery
  • Microbiome Analysis
  • Pathogen Identification
• Environmental Applications
  • Soil Microbiome Analysis
  • Water Microbiome Analysis
• Industrial Applications
  • Biofuel Production
  • Bioremediation

Global Metagenomic Sequencing Market Size by End-User & CAGR (2024-2031)

• Market Overview
• Pharmaceutical & Biotechnology Companies
  • Drug Development
  • Quality Control
• Academic & Research Institutes
  • Basic Research
  • Translational Research
• Hospitals & Clinics
  • Diagnostic Laboratories
  • Clinical Research

Global Metagenomic Sequencing Market Size & CAGR (2024-2031)

• North America (Product Type, Technology, Application, End-User)
  • USA
  • Canada
• Europe (Product Type, Technology, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Group (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PSomagen, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zymo Research Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NuGEN Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Swift Biosciences, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamilton Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations